Vanguard Group Inc Eagle Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 640,754 shares of EGRX stock, worth $2.92 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
640,754
Previous 638,124
0.41%
Holding current value
$2.92 Million
Previous $3.34 Million
0.6%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding EGRX
# of Institutions
94Shares Held
10.4MCall Options Held
3KPut Options Held
36.3K-
Nantahala Capital Management, LLC New Canaan, CT1.26MShares$5.73 Million0.42% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.19MShares$5.4 Million2.51% of portfolio
-
Black Rock Inc. New York, NY898KShares$4.09 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT879KShares$4 Million0.01% of portfolio
-
Morgan Stanley New York, NY375KShares$1.71 Million0.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $59.2M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...